Clinical Trial Update: Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV [NA]

View source ↗

Summary

A National Heart, Lung, and Blood Institute-sponsored trial evaluated acipimox for improving hyperlipidemia and insulin sensitivity in HIV-infected individuals;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection
• Heart Disease
• Hyperlipidemia
• Hypertriglyceridemia
• Insulin Resistance

Drugs mentioned

• Acipimox (Acipimox)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Insulin Resistance, Cardiovascular Diseases | NA | Status: COMPLETED